A Label-Free and Ultrasensitive Immunosensor for Detection of Human Chorionic Gonadotrophin Based on Graphene FETs
Open Access
- 12 July 2017
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 7 (3), 27
- https://doi.org/10.3390/bios7030027
Abstract
We report on a label-free immunosensor based on graphene field effect transistors (G-FETs) for the ultrasensitive detection of Human Chorionic Gonadotrophin (hCG), as an indicator of pregnancy and related disorders, such as actopic pregnancy, choriocarcinoma and orchic teratoma. Pyrene based bioactive ester was non-covalently anchored onto the graphene channel in order to retain the sp2 lattice. The G-FET transfer characteristics showed repeatable and reliable responses in all surface modifying steps using a direct current (DC) readout system. The hCG concentration gradient showed a detection limit of ~1 pg·mL−1. The proposed method facilitates the cost-effective and viable production of graphene point-of-care devices for clinical diagnosis.Keywords
Funding Information
- EPSRC (EP/M006301/1)
This publication has 33 references indexed in Scilit:
- Effect of back-gate on contact resistance and on channel conductance in graphene-based field-effect transistorsDiamond and Related Materials, 2013
- Ultrasensitive Flexible Graphene Based Field-Effect Transistor (FET)-Type Bioelectronic NoseNano Letters, 2012
- Graphene in biosensingMaterials Today, 2011
- Recent advances in graphene-based biosensorsBiosensors and Bioelectronics, 2011
- Large-Area Synthesis of High-Quality and Uniform Graphene Films on Copper FoilsScience, 2009
- Detection of individual gas molecules adsorbed on grapheneNature Materials, 2007
- The classification, functions and clinical use of different isoforms of HCGHuman Reproduction Update, 2006
- Electric Field Effect in Atomically Thin Carbon FilmsScience, 2004
- Elevated hCG and a high proportion of hCGβ in serum preceding the diagnosis of trophoblastic disease by seven monthsBJOG: An International Journal of Obstetrics and Gynaecology, 2002
- Elevated hCG and a high proportion of hCGβ in serum preceding the diagnosis of trophoblastic disease by seven monthsBJOG: An International Journal of Obstetrics and Gynaecology, 2002